Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

974 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factoring patients' beliefs and values into decisions around anticoagulation: a community-led multi-cycle quality improvement project.
Smith N, Williams L, Harding S, Singh K, Soomro DES, Alawi S, Chowdhury M, Deogan V, Parker E, Henson A, Easton F, Leung N, Staples A, Srivastava S, Adamali H, Barratt SL. Smith N, et al. Among authors: leung n. Future Healthc J. 2023 Nov;10(3):301-305. doi: 10.7861/fhj.2023-0034. Future Healthc J. 2023. PMID: 38162220 Free PMC article.
Animal-derived medicinal products: community representatives' views of their use.
Harding S, Williams L, Smith N, Soomro DES, Allawi S, Singh K, Chowdhury M, Deogan V, Staples A, Leung N, Srivastava S, Adamali H, Barratt SL. Harding S, et al. Among authors: leung n. Future Healthc J. 2023 Nov;10(3):291-295. doi: 10.7861/fhj.2023-0005. Future Healthc J. 2023. PMID: 38162195 Free PMC article.
Monoclonal Immunoglobulin Crystalline Nephropathies.
Nasr SH, Sirac C, Leung N, Bridoux F. Nasr SH, et al. Among authors: leung n. Kidney Int. 2024 May 7:S0085-2538(24)00319-3. doi: 10.1016/j.kint.2024.02.027. Online ahead of print. Kidney Int. 2024. PMID: 38723749
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
Zanwar S, Gertz MA, Muchtar E, Buadi FK, Kourelis T, Gonsalves W, Go RS, Hayman S, Kapoor P, Binder M, Cook J, Dingli D, Leung N, Lin Y, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Rajkumar SV, Kumar S, Dispenzieri A. Zanwar S, et al. Among authors: leung n. Leukemia. 2024 Apr 9. doi: 10.1038/s41375-024-02243-5. Online ahead of print. Leukemia. 2024. PMID: 38594348 No abstract available.
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: leung n. Blood Cancer J. 2024 Mar 26;14(1):55. doi: 10.1038/s41408-024-01039-1. Blood Cancer J. 2024. PMID: 38531841 Free PMC article.
974 results